Brazilian company Precisa Medicamentos, representing India's Bharat Biotech, on Monday, said it requested that the country's health regulator, Anvisa, grant emergency authorization to use the Covaxin Covid-19 vaccine.
In addition, it said Covaxin would be trialled in a Phase III study in Brazil carried out in partnership with Sao Paulo's Albert Einstein hospital.
Published 09 March 2021, 01:20 IST